Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Sarcoma 13Sarcoma, Kaposi 4Sarcoma, Ewing 4Leiomyosarcoma 4Rhabdomyosarcoma 3Osteosarcoma 3Liposarcoma 3Breast Neoplasms 3AIDS-related Kaposi sarcoma 3Sarcoma, Synovial 2Pancreatic Neoplasms 2Histiocytoma, Malignant Fibrous 2Acquired Immunodeficiency Syndrome 2Small Cell Lung Carcinoma 1Ovarian Neoplasms 1Neurofibrosarcoma 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Multi-centric Castleman's Disease 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Kidney Neoplasms 1Hereditary Sensory and Autonomic Neuropathies 1Gliosarcoma 1Glioma 1Glioblastoma 1Desmoid Tumors 1

Interventions

tocilizumab 1pomalidomide 1liposomal doxorubicin 1Zidovudine 1Valganciclovir 1Polymerase Chain Reaction 1Histological Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multi-centric Castleman's Disease × liposomal doxorubicin × Sarcoma × Clear all
NCT02659930 2026-06-04

Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 1 Active not recruiting
62 enrolled
Sarcoma

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡